Danske Bank’s China Pharma Holdings CPHI Stock Holding History

Danske Bank’s Portfolio CPHI Stock Details CPHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1	Hold	1	–	–	﹤0.01%	1136
2026 Q1	$1	Hold	1	–	–	﹤0.01%	1161
2025 Q4	$1	Hold	1	–	–	﹤0.01%	1549
2025 Q3	$2	Hold	1	–	–	﹤0.01%	1467
2025 Q2	$2	Buy	+1	New	+$2	﹤0.01%	1497

Other funds holding CPHI

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

EFG International Zurich $5.46B AUM

Danske Bank's CPHI Position: Q2 2026 in Review

Danske Bank held its China Pharma Holdings (CPHI) position steady in Q2 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #1136.

Danske Bank first reported a position in CPHI in Q2 2025 and has held it in 5 quarters since. The position peaked at $2 in Q3 2025. 8 funds tracked by Wall St. Rank hold CPHI as of Q2 2026.

Danske Bank held 1 share of China Pharma Holdings worth $1 as of Q2 2026.
Danske Bank left its China Pharma Holdings share count unchanged in Q2 2026.
China Pharma Holdings made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #1136 holding.
Danske Bank first reported a position in China Pharma Holdings in Q2 2025 and has held it in 5 quarters since.
Danske Bank's China Pharma Holdings position peaked at $2 in Q3 2025.
8 funds tracked by Wall St. Rank held China Pharma Holdings as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.